Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	entity_8	entity_9	entity_10	entity_11	entity_12	entity_13	json	split
In only 3 out of 13 cases, representing patients with adenocarcinomas of the stomach receiving chemotherapy, was ras p21 detected at elevated levels, whereas in patients with the following types of cancer no substantial change in serum ras p21 was observed; nine with breast, 5 colon, 5 lung, 5 ovarian and 5 hepatocellular carcinomas.	patients,40,48,Organism	adenocarcinomas,54,69,Cancer	stomach,77,84,Organ	ras p21,113,120,Gene_or_gene_product	patients,161,169,Organism	cancer,198,204,Cancer	serum,230,235,Organism_substance	ras p21,236,243,Gene_or_gene_product	breast,268,274,Cancer	colon,278,283,Cancer	lung,287,291,Cancer	ovarian,295,302,Cancer	hepatocellular carcinomas,309,334,Cancer	"[{""token"": ""patients"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Organism""}, {""token"": ""adenocarcinomas"", ""start_span"": 54, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""stomach"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Organ""}, {""token"": ""ras p21"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 161, ""end_span"": 169, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 198, ""end_span"": 204, ""type"": ""Cancer""}, {""token"": ""serum"", ""start_span"": 230, ""end_span"": 235, ""type"": ""Organism_substance""}, {""token"": ""ras p21"", ""start_span"": 236, ""end_span"": 243, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast"", ""start_span"": 268, ""end_span"": 274, ""type"": ""Cancer""}, {""token"": ""colon"", ""start_span"": 278, ""end_span"": 283, ""type"": ""Cancer""}, {""token"": ""lung"", ""start_span"": 287, ""end_span"": 291, ""type"": ""Cancer""}, {""token"": ""ovarian"", ""start_span"": 295, ""end_span"": 302, ""type"": ""Cancer""}, {""token"": ""hepatocellular carcinomas"", ""start_span"": 309, ""end_span"": 334, ""type"": ""Cancer""}]"	train
T - cell lines established from human T - cell leukemia - lymphoma virus associated T - cell neoplasias, in contrast to the T - cell acute lymphocytic leukemia cell lines, expressed both DR antigens and DR alpha mRNA; the HpaII sites within the BglII fragment of DR alpha DNA of these human T - cell leukemia - lymphoma virus - positive T - cell lines were in all cases at least partially unmethylated.	T - cell lines,0,14,Cell	human T - cell leukemia - lymphoma virus,32,72,Organism	T - cell neoplasias,84,103,Pathological_formation	T - cell acute lymphocytic leukemia cell lines,124,170,Cell	DR antigens,187,198,Gene_or_gene_product	DR alpha,203,211,Gene_or_gene_product	HpaII,222,227,Gene_or_gene_product	BglII,245,250,Gene_or_gene_product	fragment,251,259,Cellular_component	DR alpha,263,271,Gene_or_gene_product	DNA,272,275,Cellular_component	human T - cell leukemia - lymphoma virus,285,325,Organism	T - cell lines,337,351,Cell	"[{""token"": ""T - cell lines"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Cell""}, {""token"": ""human T - cell leukemia - lymphoma virus"", ""start_span"": 32, ""end_span"": 72, ""type"": ""Organism""}, {""token"": ""T - cell neoplasias"", ""start_span"": 84, ""end_span"": 103, ""type"": ""Pathological_formation""}, {""token"": ""T - cell acute lymphocytic leukemia cell lines"", ""start_span"": 124, ""end_span"": 170, ""type"": ""Cell""}, {""token"": ""DR antigens"", ""start_span"": 187, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}, {""token"": ""DR alpha"", ""start_span"": 203, ""end_span"": 211, ""type"": ""Gene_or_gene_product""}, {""token"": ""HpaII"", ""start_span"": 222, ""end_span"": 227, ""type"": ""Gene_or_gene_product""}, {""token"": ""BglII"", ""start_span"": 245, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""fragment"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Cellular_component""}, {""token"": ""DR alpha"", ""start_span"": 263, ""end_span"": 271, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 272, ""end_span"": 275, ""type"": ""Cellular_component""}, {""token"": ""human T - cell leukemia - lymphoma virus"", ""start_span"": 285, ""end_span"": 325, ""type"": ""Organism""}, {""token"": ""T - cell lines"", ""start_span"": 337, ""end_span"": 351, ""type"": ""Cell""}]"	train
The present study was therefore designed to evaluate the expression of thrombospondin 1 and 2 ( TSP - 1, TSP - 2), TSP receptors CD36 and CD47, and matrix - metalloproteases 2 and 9 ( MMP -, MMP - 9) in a rat prostate cancer model.	thrombospondin 1,71,87,Gene_or_gene_product	2,92,93,Gene_or_gene_product	TSP - 1,96,103,Gene_or_gene_product	TSP - 2,105,112,Gene_or_gene_product	TSP,115,118,Gene_or_gene_product	CD36,129,133,Gene_or_gene_product	CD47,138,142,Gene_or_gene_product	matrix - metalloproteases 2,148,175,Gene_or_gene_product	9,180,181,Gene_or_gene_product	MMP,184,187,Gene_or_gene_product	MMP - 9,191,198,Gene_or_gene_product	rat,205,208,Organism	prostate cancer,209,224,Cancer	"[{""token"": ""thrombospondin 1"", ""start_span"": 71, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 92, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 2"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD36"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD47"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix - metalloproteases 2"", ""start_span"": 148, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""9"", ""start_span"": 180, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 191, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Organism""}, {""token"": ""prostate cancer"", ""start_span"": 209, ""end_span"": 224, ""type"": ""Cancer""}]"	valid
In this study, we demonstrate that two independent downstream signal pathways, DCN / EGFR / ERK1 / 2 and DCN / EGFR / phosphoinositide - 3 kinase / AKT, mediate up - regulation and activation of transcription factors of VEGF such as HIF1alpha, Stat3, and Sp1 and increase VEGF transcription and angiogenesis in MCE cells.	DCN,79,82,Gene_or_gene_product	EGFR,85,89,Gene_or_gene_product	ERK1 / 2,92,100,Gene_or_gene_product	DCN,105,108,Gene_or_gene_product	EGFR,111,115,Gene_or_gene_product	phosphoinositide - 3 kinase,118,145,Gene_or_gene_product	AKT,148,151,Gene_or_gene_product	VEGF,220,224,Gene_or_gene_product	HIF1alpha,233,242,Gene_or_gene_product	Stat3,244,249,Gene_or_gene_product	Sp1,255,258,Gene_or_gene_product	VEGF,272,276,Gene_or_gene_product	MCE cells,311,320,Cell	"[{""token"": ""DCN"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGFR"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK1 / 2"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""DCN"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGFR"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphoinositide - 3 kinase"", ""start_span"": 118, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 220, ""end_span"": 224, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF1alpha"", ""start_span"": 233, ""end_span"": 242, ""type"": ""Gene_or_gene_product""}, {""token"": ""Stat3"", ""start_span"": 244, ""end_span"": 249, ""type"": ""Gene_or_gene_product""}, {""token"": ""Sp1"", ""start_span"": 255, ""end_span"": 258, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 272, ""end_span"": 276, ""type"": ""Gene_or_gene_product""}, {""token"": ""MCE cells"", ""start_span"": 311, ""end_span"": 320, ""type"": ""Cell""}]"	valid
Non - specific PKC inhibitors staurosporine and bisindolylmaleimide II as well as inhibitors specific to conventional PKCs ( Go6976) and PKC - delta ( rottlerin) attenuated NF - kappaB activation in BPDE treated cells to a varying degree indicating a possible link between PKC down - regulation and the attenuation of NF - kappaB activity by TSC phenolic fraction.	PKC,15,18,Gene_or_gene_product	staurosporine,30,43,Chemical	bisindolylmaleimide II,48,70,Chemical	PKCs,118,122,Gene_or_gene_product	Go6976,125,131,Chemical	PKC - delta,137,148,Gene_or_gene_product	rottlerin,151,160,Chemical	NF - kappaB,173,184,Gene_or_gene_product	BPDE,199,203,Chemical	cells,212,217,Cell	PKC,273,276,Gene_or_gene_product	NF - kappaB,318,329,Gene_or_gene_product	TSC phenolic fraction,342,363,Chemical	"[{""token"": ""PKC"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""staurosporine"", ""start_span"": 30, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""bisindolylmaleimide II"", ""start_span"": 48, ""end_span"": 70, ""type"": ""Chemical""}, {""token"": ""PKCs"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""Go6976"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Chemical""}, {""token"": ""PKC - delta"", ""start_span"": 137, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""rottlerin"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Chemical""}, {""token"": ""NF - kappaB"", ""start_span"": 173, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""BPDE"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 212, ""end_span"": 217, ""type"": ""Cell""}, {""token"": ""PKC"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 318, ""end_span"": 329, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSC phenolic fraction"", ""start_span"": 342, ""end_span"": 363, ""type"": ""Chemical""}]"	valid
Antibodies against beta ( 2) M or MHC class I induce tumor cell apoptosis by 1) recruiting MHC class I molecules to lipid rafts and activating LYN kinase and the signal - transducing enzyme phospholipase C - gamma2 - dependent c - Jun N - terminal kinase signaling pathway and 2) expelling interleukin 6 and insulin - like growth factor 1 receptors out of lipid rafts and inhibiting the growth and survival factor - induced activation of the phosphatidylinositol 3 - kinase / Akt and extracellular signal - related kinase pathways.	MHC class I,34,45,Gene_or_gene_product	tumor cell,53,63,Cell	MHC class I,91,102,Gene_or_gene_product	lipid rafts,116,127,Cellular_component	LYN,143,146,Gene_or_gene_product	phospholipase C - gamma2,190,214,Gene_or_gene_product	c - Jun N - terminal kinase,227,254,Gene_or_gene_product	interleukin 6,290,303,Gene_or_gene_product	insulin - like growth factor 1 receptors,308,348,Gene_or_gene_product	lipid rafts,356,367,Cellular_component	phosphatidylinositol 3 - kinase,442,473,Gene_or_gene_product	Akt,476,479,Gene_or_gene_product	extracellular signal - related kinase,484,521,Gene_or_gene_product	"[{""token"": ""MHC class I"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cell"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""MHC class I"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""lipid rafts"", ""start_span"": 116, ""end_span"": 127, ""type"": ""Cellular_component""}, {""token"": ""LYN"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""phospholipase C - gamma2"", ""start_span"": 190, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Jun N - terminal kinase"", ""start_span"": 227, ""end_span"": 254, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin 6"", ""start_span"": 290, ""end_span"": 303, ""type"": ""Gene_or_gene_product""}, {""token"": ""insulin - like growth factor 1 receptors"", ""start_span"": 308, ""end_span"": 348, ""type"": ""Gene_or_gene_product""}, {""token"": ""lipid rafts"", ""start_span"": 356, ""end_span"": 367, ""type"": ""Cellular_component""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 442, ""end_span"": 473, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 476, ""end_span"": 479, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular signal - related kinase"", ""start_span"": 484, ""end_span"": 521, ""type"": ""Gene_or_gene_product""}]"	valid
Y705F / S727E mutant cells were more invasive than Y705F / S727A ( inactivation of Y705 and S727) mutant cells, and more Y705F / S727E mutant Stat3 was localized in the nuclei relative to Y705F / S727A mutant Stat3 at the steady state.	Y705F,0,5,Amino_acid	S727E,8,13,Amino_acid	Y705F,51,56,Amino_acid	S727A,59,64,Amino_acid	Y705,83,87,Amino_acid	S727,92,96,Amino_acid	Y705F,121,126,Amino_acid	S727E,129,134,Amino_acid	Stat3,142,147,Gene_or_gene_product	nuclei,169,175,Cellular_component	Y705F,188,193,Amino_acid	S727A,196,201,Amino_acid	Stat3,209,214,Gene_or_gene_product	"[{""token"": ""Y705F"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Amino_acid""}, {""token"": ""S727E"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Amino_acid""}, {""token"": ""Y705F"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Amino_acid""}, {""token"": ""S727A"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Amino_acid""}, {""token"": ""Y705"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Amino_acid""}, {""token"": ""S727"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Amino_acid""}, {""token"": ""Y705F"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Amino_acid""}, {""token"": ""S727E"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Amino_acid""}, {""token"": ""Stat3"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclei"", ""start_span"": 169, ""end_span"": 175, ""type"": ""Cellular_component""}, {""token"": ""Y705F"", ""start_span"": 188, ""end_span"": 193, ""type"": ""Amino_acid""}, {""token"": ""S727A"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Amino_acid""}, {""token"": ""Stat3"", ""start_span"": 209, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}]"	test
Oocytes in double - mutant females showed normal localization of brca2 and pou5f1 transcripts to the animal pole and vasa transcripts to the vegetal pole, but had a polarized rather than symmetrical nucleus with the distribution of nucleoli and chromosomes to opposite nuclear poles; this result revealed a novel role for Brca2 in establishing or maintaining oocyte nuclear architecture.	Oocytes,0,7,Cell	double - mutant females,11,34,Organism	brca2,65,70,Gene_or_gene_product	pou5f1,75,81,Gene_or_gene_product	animal pole,101,112,Cellular_component	vegetal pole,141,153,Cellular_component	nucleus,199,206,Cellular_component	nucleoli,232,240,Cellular_component	chromosomes,245,256,Cellular_component	nuclear poles,269,282,Cellular_component	Brca2,322,327,Gene_or_gene_product	oocyte,359,365,Cell	nuclear,366,373,Cellular_component	"[{""token"": ""Oocytes"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Cell""}, {""token"": ""double - mutant females"", ""start_span"": 11, ""end_span"": 34, ""type"": ""Organism""}, {""token"": ""brca2"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""pou5f1"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""animal pole"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Cellular_component""}, {""token"": ""vegetal pole"", ""start_span"": 141, ""end_span"": 153, ""type"": ""Cellular_component""}, {""token"": ""nucleus"", ""start_span"": 199, ""end_span"": 206, ""type"": ""Cellular_component""}, {""token"": ""nucleoli"", ""start_span"": 232, ""end_span"": 240, ""type"": ""Cellular_component""}, {""token"": ""chromosomes"", ""start_span"": 245, ""end_span"": 256, ""type"": ""Cellular_component""}, {""token"": ""nuclear poles"", ""start_span"": 269, ""end_span"": 282, ""type"": ""Cellular_component""}, {""token"": ""Brca2"", ""start_span"": 322, ""end_span"": 327, ""type"": ""Gene_or_gene_product""}, {""token"": ""oocyte"", ""start_span"": 359, ""end_span"": 365, ""type"": ""Cell""}, {""token"": ""nuclear"", ""start_span"": 366, ""end_span"": 373, ""type"": ""Cellular_component""}]"	test
